Delivery Order SPE2DB20D3505-SPE2DB22FT4V0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Medroxyprogesterone 150 mg/mL. The Firm Fixed Price delivery order, valued at $1,504.84, was awarded on February 7, 2022 with a completion date of February 8, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,659.02, is for the delivery of Medroxyprogesterone 150 mg/mL, a pharmaceutical product. The contract has a delivery order type and firm fixed price pricing structure, with a performance period ending on May 22, 2023. The contract is not designated as a set-aside and was awarded through full and...
- The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $10,459.32 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Medroxyprogesterone 150 mg/mL. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,404.20 firm fixed price delivery order contract is for the provision of Medroxyprogesterone 150 mg/ml medication. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for delivering a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,588.72 firm fixed-price delivery order covers the supply of Medroxyprogesterone 150 mg/ml, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Cencora, Inc. to deliver...
- This federal contract award, valued at $2,033.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MEDROXYPROGESTERONE 150 MG/MLML, a medical product, and has an ultimate completion date of May 29, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Medroxyprogesterone 150 mg/mL. The contract has a ceiling value of $1,511.15 and is a Firm Fixed Price Delivery Order, with a completion date of June 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,588.19 firm fixed-price delivery order is for the supply of 4560448467 Medroxyprogesterone 150 mg/ml, with an ultimate completion date of April 3, 2023. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, SPE2DB20D3505|SPE2DB25FT7F2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,254.68 firm fixed-price delivery order is for the supply of MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product, with a completion date of January 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,425,004 units of medroxyprogesterone 150 mg/ml, a prescription medication. The contract is a Delivery Order valued at $1,155.89 with a firm fixed price and an ultimate completion date of August 13, 2024. This contract is not associated with a set-aside program. Amerisourcebergen is the prime...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FT4V0Delivery Order
This federal contract award, with ID SPE2DB20D3505|SPE2DB22FT4V0, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,221.50 firm fixed-price delivery order is for the supply of Medroxyprogesterone 150 mg/mL, a pharmaceutical product. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/23/22 |